Evidence-based pricing for complex, feature-rich MedTech and subscription-based B2B products.
You may recognize this:
If this sounds familiar, you are not alone.
Here are the facts:
In 86 new product pricing studies conducted by us, only:
1 out of 86
launches would have had the right price without the pricing research.
85 out of 86 were underpriced by 10–300%
signaling a lack of value understanding.
Across existing portfolios, pricing improvements
are typically identified in the range of 7–20%
The issue is rarely the economic value.
It is unmeasured perceived value — and the absence of hard evidence on willingness to pay.
This is also the reason why 90% of our clients
realize ROI within 20–60 days after implementation.
For companies preparing for growth capital or exit, the impact is usually even greater.
We Turn Evidence into Pricing Decisions
We quantify willingness to pay and translate perceived value into executable pricing strategies.
- Structured trade-off research (including advanced conjoint methodologies)
- Measurement of true willingness to pay
- Monetization and prioritization of features
- Packaging and portfolio design
- Pricing modelling
- Strengthened discount structures and sales enablement
In fact our approach even allows to establish brand value, i.e. how much more one company may charge against a competitors for largely identical products.
It’s all evidence-based pricing translated into decisions your organization can execute.
Specialists in advanced trade-off and conjoint analysis — the gold standard for measuring willingness to pay.
“We have worked with Contribution for many years on pricing analyses related to new products and features, as well as optimization of existing ones. The collaboration has been structured and professional, with a strong understanding of our situation and needs—and the results have been outstanding. For one product, we conducted analyses before and during the development phase, and again ahead of launch. Both the product and its pricing were significantly optimized and today form the foundation of a product family generating over €400 million in global revenue.”
– Pricing Director, MedTech
“We recently approached Contribution to help us decide on customer value and pricing for 20 different product attributes and even more options, which were on the gross list for a new product platform. Contribution recommended the Advanced Choice-based conjoint methodology and conducted a research project that delivered the answers we were looking for. We were impressed by the methodology, collaboration and analysis carried out by Contribution, and would not hesitate to use them again.”
– Senior Director, Industrial manufacturer
We Deliver Measurable, Affordable Solutions.
If you would like additional information or have specific queries, please contact us: